We noted in the CY 2026 OPPS/ASC proposed rule that based on the description the applicant provided, the Axoguard HA+ Nerve Protector TM is a porcine SIS ECM with hyaluronate-alginate coating used for the management and protection of peripheral nerve injuries where there is no gap or following closure of a gap, and thus, could be encompassed by the descriptors C1763 and C1765
No IGF-1 or Growth Hormone Receptor Activation Full-length growth hormone produces complex metabolic effects including appetite stimulation through IGF-1 (insulin-like growth factor-1) production and direct growth hormone receptor activation
Oxidation and other chemical degradation: BPC-157 does not contain cysteine, the most oxidation-sensitive residue in many peptides, so the dominant oxidative risk is lower than for cysteine-containing sequences
Enter your vial size, bacteriostatic water volume, and target dose our tool instantly converts your peptide dosage into precise syringe units
Two weeks at the lowest effective dose reveals individual sensitivity